Rare diseases
Investigational molecules
Locations
Via Carro E Quattrone 8, 89134 Reggio Calabria, Italy
Associazione Qol-One funds clinical research in myelodysplastic syndromes, with a specific focus on del(5q) disease and lower-risk forms defined by IPSS-R categories. The sponsored trials address patients with limited prior treatment options and ongoing bone marrow failure.
The research landscape includes patients with very low, low, and intermediate risk disease, reflecting a therapeutic interest in clinically significant but less advanced myelodysplastic conditions.
Associazione Qol-One runs clinical trials in conditions such as Myelodysplastic syndrome, among others.
Clinical trials run by this sponsor – those enrolling participants first.
ItalyStudy on Luspatercept for Treating Anemia in Patients with Myelodysplastic Syndromes (MDS) with del5q, Resistant to Prior Treatments and Needing Blood Transfusions
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
